| Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses MO Oyewumi, A Kumar, Z Cui Expert review of vaccines 9 (9), 1095-1107, 2010 | 576 | 2010 |
| Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice MO Oyewumi, RA Yokel, M Jay, T Coakley, RJ Mumper Journal of Controlled Release 95 (3), 613-626, 2004 | 371 | 2004 |
| Brain uptake of thiamine-coated nanoparticles PR Lockman, MO Oyewumi, JM Koziara, KE Roder, RJ Mumper, DD Allen Journal of controlled release 93 (3), 271-282, 2003 | 346 | 2003 |
| Influence of formulation parameters on gadolinium entrapment and tumor cell uptake using folate-coated nanoparticles MO Oyewumi, RJ Mumper International journal of pharmaceutics 251 (1-2), 85-97, 2003 | 113 | 2003 |
| Photoresponsive coumarin polyesters that exhibit cross-linking and chain scission properties MVSN Maddipatla, D Wehrung, C Tang, W Fan, MO Oyewumi, T Miyoshi, ... Macromolecules 46 (13), 5133-5140, 2013 | 106 | 2013 |
| Engineering tumor-targeted gadolinium hexanedione nanoparticles for potential application in neutron capture therapy MO Oyewumi, RJ Mumper Bioconjugate chemistry 13 (6), 1328-1335, 2002 | 93 | 2002 |
| Gadolinium-loaded nanoparticles engineered from microemulsion templates MO Oyewumi, RJ Mumper Drug development and industrial pharmacy 28 (3), 317-328, 2002 | 91 | 2002 |
| Requisite role of Kv1. 5 channels in coronary metabolic dilation V Ohanyan, L Yin, R Bardakjian, C Kolz, M Enrick, T Hakobyan, J Kmetz, ... Circulation research 117 (7), 612-621, 2015 | 89 | 2015 |
| Specific association of thiamine-coated gadolinium nanoparticles with human breast cancer cells expressing thiamine transporters MO Oyewumi, S Liu, JA Moscow, RJ Mumper Bioconjugate chemistry 14 (2), 404-411, 2003 | 75 | 2003 |
| 3D printing technology in pharmaceutical drug delivery: prospects and challenges AH Jassim-Jaboori, MO Oyewumi J Biomol Res Ther 4 (4), e141, 2015 | 58 | 2015 |
| Nanotemplate engineering of cell specific nanoparticles RJ Mumper, Z Cui, MO Oyewumi Journal of dispersion science and technology 24 (3-4), 569-588, 2003 | 49 | 2003 |
| Behavior of partially fluorinated carboxylic acids at the air–water interface HJ Lehmler, MO Oyewumi, M Jay, PM Bummer Journal of fluorine chemistry 107 (1), 141-146, 2001 | 49 | 2001 |
| Critical assessment of implantable drug delivery devices in glaucoma management D Manickavasagam, MO Oyewumi Journal of drug delivery 2013, 2013 | 48 | 2013 |
| Nanotechnology in drug development and life cycle management S Majuru, MO Oyewumi Nanotechnology in drug delivery, 597-619, 2009 | 47 | 2009 |
| Osteoactivin (GPNMB) ectodomain protein promotes growth and invasive behavior of human lung cancer cells MO Oyewumi, D Manickavasagam, K Novak, D Wehrung, N Paulic, ... Oncotarget 7 (12), 13932, 2016 | 36 | 2016 |
| Antitumor effect of novel gallium compounds and efficacy of nanoparticle-mediated gallium delivery in lung cancer D Wehrung, MO Oyewumi Journal of Biomedical Nanotechnology 8 (1), 161-171, 2012 | 31 | 2012 |
| Integration of 3D printing technology in pharmaceutical compounding: Progress, prospects, and challenges LA Melnyk, MO Oyewumi Annals of 3D Printed Medicine 4 (100035), 2666-9641, 2021 | 30 | 2021 |
| Delivery systems as vital tools in drug repurposing T Czech, R Lalani, MO Oyewumi AAPS PharmSciTech 20 (3), 116, 2019 | 28 | 2019 |
| Effects of gelucire content on stability, macrophage interaction and blood circulation of nanoparticles engineered from nanoemulsions D Wehrung, WJ Geldenhuys, MO Oyewumi Colloids and Surfaces B: Biointerfaces 94, 259-265, 2012 | 27 | 2012 |
| Emerging lung cancer therapeutic targets based on the pathogenesis of bone metastases MO Oyewumi, A Alazizi, D Wehrung, R Manochakian, FF Safadi International Journal of Cell Biology 2014, 2014 | 25 | 2014 |
Russell J. Mumper, Ph.D.Vice President for Research, Indiana UniversityVerified email at iu.edu
